Using immunofluorescence, we examined additional tumor marker genes and found that all tumors co-transplanted with UCP1-CRISPRa-modulated human adipose organoids had markedly reduced Ki67+ cells (Fig. 2c). This evidence concerns the gene UCP1 and neoplasm.